Status:

COMPLETED

Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19

Lead Sponsor:

aTyr Pharma, Inc.

Conditions:

SARS-CoV-2 (COVID-19) Severe Pneumonia

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

To evaluate the safety and preliminary efficacy of efzofitimod, compared to placebo matched to efzofitimod, in hospitalized participants with SARS-CoV-2 (COVID-19) severe pneumonia not requiring mecha...

Eligibility Criteria

Inclusion

  • Confirmation of SARS-CoV-2 infection by polymerase chain reaction (PCR).
  • Severe pneumonia related to SARS-CoV-2 infection, defined as fever or suspected respiratory infection with radiographic abnormalities suggestive of viral pneumonia, plus at least 1 of the following:
  • Respiratory rate \>30 breaths/minute;
  • Severe respiratory distress, as determined by the Investigator;
  • Oxygen saturation (SpO2) ≤93% on room air.

Exclusion

  • Participant is intubated/mechanically ventilated.
  • In the opinion of the Investigator, participant's progression to death is imminent.
  • Treatment with immunosuppressant/immunotherapy drugs, including but not limited to interleukin (IL)-6 inhibitors, tumor necrosis factor-alpha (TNF-α) inhibitors, anti-IL-1 agents and janus kinase inhibitors within 5 half-lives or 30 days prior to Day 1.
  • Use of chronic (\>30 days) oral corticosteroids for a non-COVID-19-related condition in a dose higher than prednisone 10 mg or equivalent per day.
  • Weight \>165 kg or \<40 kg.

Key Trial Info

Start Date :

June 4 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 23 2020

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT04412668

Start Date

June 4 2020

End Date

October 23 2020

Last Update

August 18 2023

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294

2

aTyr Investigative Site

Washington D.C., District of Columbia, United States, 20010

3

University of Miami

Miami, Florida, United States, 33125

4

University of Iowa

Iowa City, Iowa, United States, 52242